Amalgamated Bank Gossamer Bio, Inc. Transaction History

Amalgamated Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$0.96 - $2.92 $1,269 - $3,860	-1,322 Reduced 13.16%	8,727 $11,000
Q3 2022 Nov 09, 2022	BUY	$7.21 - $14.88 $1,153 - $2,380	160 Added 1.62%	10,049 $120,000
Q2 2022 Aug 15, 2022	BUY	$5.97 - $9.97 $14,345 - $23,957	2,403 Added 32.1%	9,889 $83,000
Q1 2022 Jun 30, 2022	BUY	$8.44 - $12.49 $63,181 - $93,500	7,486 New	7,486 $65,000

109

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $84.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.